Combination therapy of newly diagnosed intermediate-risk pulmonary arterial hypertension: A review
Consilium Medicum(2022)
摘要
Advancements in the specific therapy of pulmonary arterial hypertension (PAH) and new combination therapy strategies and escalation treatment over the past decade have significantly improved disease control, slowed its progression, and improved quality of life and patient survival. This review provides a detailed discussion of current strategies for PAH-specific therapy available in the Russian Federation for patients with classical and non-classical PAH who fail to achieve treatment goals and remain at intermediate risk of disease progression/mortality.
更多查看译文
关键词
pulmonary arterial hypertension,intermediate risk of mortality,pah-specific therapy,initial combination therapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要